// App-Quantinova.ai

240 : Primary and Secondary Non-Response in RA Patients Treated with an Anti-TNF: An Analysis from a Prospective, Observational Registry

Researchers

Presenter

  • Philip Baer

Principal Investigators

  • Wojciech Olszynski

  • Brendan Osborne

  • Cathy Tkaczyk

  • Karina Maslova

  • Boulos Haraoui

  • William Bensen

  • Rafat Faraawi

  • Milton Baker

  • Emmanouil Rampakakis

  • John Sampalis

  • Allen Lehman

  • Francois Nantel

Medical Centers

  • Institut de Rhumatologie, Montreal, QC, Canada

  • University of Victoria, Victoria, BC, Canada

  • St Michael's Hospital, University of Toronto, Toronto, ON, Canada

  • McMaster University, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

  • University of Saskatchewan, Saskatoon, SK, Canada

Locations

  • Canada

Companies

  • JSS Medical Research

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Psoriatic arthritis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • golimumab

Outcome

  • Unknown

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved